Cargando…

Endothelial Nitric Oxide Synthase Glu298Asp Gene Polymorphism is Associated with Hypertensive Response to Exercise in Well-Controlled Hypertensive Patients

PURPOSE: Hypertensive response to exercise (HRE) is known to be an adverse prognostic factor for future cardiovascular events and may be associated to endothelial dysfunction. Previous studies regarding endothelial nitric oxide synthase (eNOS) Glu298Asp polymorphism focused upon its relation to hype...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jung-Sun, Cho, Jung Rae, Park, Sungha, Shim, Jaemin, Kim, Jin-Bae, Cho, Deok-Kyu, Shin, Hyun-Joon, Park, Chan Mi, Ko, Young-Guk, Ha, Jong-Won, Choi, Donghoon, Rim, Se-Joong, Jang, Yangsoo, Chung, Namsik
Formato:	Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2007
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628106/ https://www.ncbi.nlm.nih.gov/pubmed/17594145 http://dx.doi.org/10.3349/ymj.2007.48.3.389

Ejemplares similares

Association of endothelial nitric oxide synthase Glu298Asp gene polymorphism in psoriasis cases with hypertension
por: Ogretmen, Zerrin, et al.
Publicado: (2014)

Endothelial nitric oxide synthase gene Glu298Asp polymorphism in patients with coronary artery disease
por: Salimi, Saeedeh, et al.
Publicado: (2010)

Endothelial nitric oxide synthase Glu298Asp gene polymorphism in the cases of idiopathic thrombocytopenic purpura
por: Akarsu, Saadet, et al.
Publicado: (2022)

A common variant of endothelial nitric oxide synthase (Glu298Asp) is associated with collateral development in patients with chronic coronary occlusions
por: Lamblin, Nicolas, et al.
Publicado: (2005)

Prevalence of endothelial nitric oxide synthase (eNOS) gene exon 7 Glu298Asp variant in North Eastern India
por: Shankarishan, Priyanka, et al.
Publicado: (2011)

Association of endothelial nitric oxide synthase (Glu298Asp) gene polymorphism with radial artery spasm during cardiac catheterization in Egyptians
por: Abdelaziz, Tarek A, et al.
Publicado: (2023)

Association of Plasma Retinol-Binding Protein 4, Adiponectin, and High Molecular Weight Adiponectin with Insulin Resistance in Non-Diabetic Hypertensive Patients
por: Shim, Chi Young, et al.
Publicado: (2010)

Association of Endothelial Dysfunction with Endothelin, Nitric Oxide and eNOS Glu298Asp Gene Polymorphism in Coronary Artery Disease
por: Saini, Vandana, et al.
Publicado: (2011)

Combined effects of cigarette smoking, alcohol drinking and eNOS Glu298Asp polymorphism on blood pressure in Chinese male hypertensive subjects
por: Hong, Zhe, et al.
Publicado: (2019)

Polymorphisms in the Renin-Angiotensin System and eNOS Glu298Asp Genes Are Associated with Increased Risk for Essential Hypertension in a Mexican Population
por: Isordia-Salas, Irma, et al.
Publicado: (2023)

Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and development of pre-eclampsia: a case-control study and a meta-analysis
por: Yu, Christina KH, et al.
Publicado: (2006)

Increase of Metabolic Syndrome Score is an Independent Determinant of Increasing Pulse Pressure
por: Moon, Jae-Youn, et al.
Publicado: (2008)

Endothelial nitric oxide synthase Glu 298 Asp (G894T) and Apolipoprotein E gene polymorphism as possible risk factors for coronary heart disease among Egyptians
por: Arafa, Sherif, et al.
Publicado: (2018)

Endothelial nitric oxide synthase Asp298Glu (894G/T) gene polymorphism as a possible risk factor for the coronary slow flow phenomenon among Iranians
por: Karimi, Yeganeh, et al.
Publicado: (2022)

Right Ventricular Adaptation Is Associated with the Glu298Asp Variant of the NOS3 Gene in Elite Athletes
por: Szelid, Zsolt, et al.
Publicado: (2015)

The Asp(298 )allele of endothelial nitric oxide synthase is a risk factor for myocardial infarction among patients with type 2 diabetes mellitus
por: Odeberg, Jacob, et al.
Publicado: (2008)

Human Evaluation of the Glu298Asp Polymorphism in NOS3 Gene and its Relationship with Onset age of ESRD in Iranian Patients Suffering from ADPKD
por: dasar, Negin, et al.
Publicado: (2012)

Impact of Ambulatory Blood Pressure on Early Cardiac and Renal Dysfunction in Hypertensive Patients without Clinically Apparent Target Organ Damage
por: Kim, Darae, et al.
Publicado: (2018)

Nonautoimmune congenital hyperthyroidism due to p.Asp633Glu mutation in the TSHR gene
por: Cho, Won Kyoung, et al.
Publicado: (2018)

Association between Serine/Threonine Kinase 39 Gene Polymorphism, Hypertension, and Other Cardiovascular Risk Factors in Koreans
por: Shin, Dong-Jik, et al.
Publicado: (2013)

Differences in left ventricular functional adaptation to arterial stiffness and neurohormonal activation in patients with hypertension: a study with two-dimensional layer-specific speckle tracking echocardiography
por: Kim, Darae, et al.
Publicado: (2017)

Development of a New Hybrid Biodegradable Drug-Eluting Stent for the Treatment of Peripheral Artery Disease
por: Lee, Jung-Hee, et al.
Publicado: (2016)

Morning Hypertension in Treated Hypertensives: Baseline Characteristics and Clinical Implications
por: Lee, Ju-Hee, et al.
Publicado: (2011)

Ideal Target Blood Pressure in Hypertension
por: Park, Sungha
Publicado: (2019)

Association of CYP2C19(*)2 and (*)3 Genetic Variants with Essential Hypertension in Koreans
por: Shin, Dong-Jik, et al.
Publicado: (2012)

Angiopoietin-1 Gene Therapy Attenuates Hypertension and Target Organ Damage in Nitric Oxide Synthase Inhibited Spontaneously Hypertensive Rats
por: Suh, Wonhee, et al.
Publicado: (2011)

The Renalase Asp37Glu polymorphism is not associated with hypertension and cardiovascular events in an urban-based prospective cohort: the Malmö Diet and cancer study
por: Fava, Cristiano, et al.
Publicado: (2012)

Association of Morning Hypertension Subtype With Vascular Target Organ Damage and Central Hemodynamics
por: Oh, Jaewon, et al.
Publicado: (2017)

The 2022 focused update of the 2018 Korean Hypertension Society Guidelines for the management of hypertension
por: Kim, Hack-Lyoung, et al.
Publicado: (2023)

Increased Inflammation, Reduced Plasma Phospholipid Eicosapentaenoic Acid and Reduced Antioxidant Potential of Treated Hypertensive Patients with Metabolic Syndrome
por: Shin, Min-Jeong, et al.
Publicado: (2009)

Statement on chronotherapy for the treatment of hypertension: consensus document from the Korean society of hypertension
por: Park, Sungha, et al.
Publicado: (2023)

Resistant hypertension: consensus document from the Korean society of hypertension
por: Park, Sungha, et al.
Publicado: (2023)

Development of Advanced Atherosclerotic Plaque by Injection of Inflammatory Proteins in a Rabbit Iliac Artery Model
por: Kim, Jung-Sun, et al.
Publicado: (2016)

Neuronal nitric oxide synthase in hypertension – an update
por: Zhang, Yin Hua
Publicado: (2016)

2018 Korean Society of Hypertension guidelines for the management of hypertension: part I-epidemiology of hypertension
por: Kim, Hyeon Chang, et al.
Publicado: (2019)

A Multicenter, Randomized, Open-Label, Therapeutic, and Exploratory Trial to Evaluate the Tolerability and Efficacy of Platelet Glycoprotein IIb/IIIa Receptor Blocker (Clotinab™) in High-Risk Patients with Percutaneous Coronary Intervention
por: Moon, Jae-Youn, et al.
Publicado: (2008)

Comparison of Optical Coherence Tomographic Assessment between First- and Second-Generation Drug-Eluting Stents
por: Kim, Byeong-Keuk, et al.
Publicado: (2012)

Comparison of First-Line Dual Combination Treatments in Hypertension: Real-World Evidence from Multinational Heterogeneous Cohorts
por: You, Seng Chan, et al.
Publicado: (2019)

2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension
por: Lee, Hae-Young, et al.
Publicado: (2019)

2018 Korean society of hypertension guidelines for the management of hypertension: part III-hypertension in special situations
por: Kim, Kwang-il, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6s5cb94fagbduaq621ob6mlski